Implementation of Long-acting Cabotegravir + Rilpivirine Administration Out of "HIV Units".
Latest Information Update: 16 Jun 2025
At a glance
- Drugs Cabotegravir (Primary) ; Rilpivirine (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms IMAdART
Most Recent Events
- 10 Jun 2025 Planned End Date changed from 1 Dec 2025 to 15 Jul 2025.
- 10 Jun 2025 Status changed from not yet recruiting to active, no longer recruiting.
- 12 Dec 2023 New trial record